Professor Tsui Hark 1982 graduated from China Medical University, and 1990 went to Hamamatsu Medical University to study, focusing on "Interventional Therapy for Budd-Chiari Syndrome" and obtained a doctorate. Continue to carry out research work in the field of interventional therapy after returning to China. He pioneered the treatment of segmental Budd-Chiari syndrome by opening inferior vena cava occlusion, Budd-Chiari syndrome by opening hepatic vein occlusion via jugular vein and/or percutaneous hepatic vein, portal hypertension complicated with upper gastrointestinal bleeding by TIPS combined with SEEV, and acute deep venous thrombosis of lower limbs by jugular vein thrombosis aspiration. Transcatheter arterial chemoembolization (TACE) is a new interventional technique for the treatment of blood vessels and tumors such as liver cancer. It has obtained four national patents and has been invited to dozens of hospitals in more than 20 provinces and cities across the country for surgical demonstration and technical popularization, and achieved good results. Up to now, the first finisher has won national and provincial awards 12, including the second prize of national scientific and technological progress 1, the third prize of national scientific and technological progress 1, the second prize of China scientific and technological progress, and the first prize of Liaoning scientific and technological progress.

In recent years, Professor Tsui Hark has edited 5 monographs and participated in 6 monographs. Published nearly 200 papers in core journals of radiology; During the "Ninth Five-Year Plan" and "Eleventh Five-Year Plan" period, he has presided over and undertaken more than 40 national key scientific and technological projects and won 3 national patents. Won 16 national and provincial science and technology progress award. Among them, in 2007, it won the "Eleventh Five-Year" Science and Technology Support Plan 1 item; In 2008, he won the second prize of National Science and Technology Progress Award. 20 1 1 In September, Xu Ke took the lead in undertaking the national "Twelfth Five-Year Plan" 863 project "New Technology Development and Product Application Research for Minimally Invasive Treatment of Malignant Tumors", and successively won honorary titles such as the National Excellent Dean, the Fifth China Physician Award of the Chinese Medical Doctor Association, the National May 1st Labor Medal, the National Advanced Worker, the National Excellent Scientific and Technological Worker and the Young and Middle-aged Expert with Outstanding Contributions from the Ministry of Health. Professor Tsui Hark won the 20 12 "China Top 100 Doctoral List".